Prognosis of 980 patients with gastric cancer after surgical resection

Wei Wang, Yuan-Fang Li, Xiao-Wei Sun, YingBo Chen, Wei Li, DaZhi Xu, XuanXiang Guan, ChunYu Huang, YouQing Zhan, ZhiWei Zhou
2010-11-01
Abstract:Currently, the worldwide incidence of gastric cancer is descending, however, in China gastric cancer is still one of the most common malignant tumors, and the number of new cases per year is larger than that in other countries [1]. Although perioperative adjuvant chemotherapy or neoadjuvant chemotherapy for advanced gastric cancer attracts more and more attention and the genes and molecular targets are deeply studied, surgery is still the only possible means to cure gastric cancer, and postoperative clinical pathologic classification (TNM classification) can best predict prognosis of the patients. TNM staging system was established based on the most fundamental and important factors which influence the prognosis of patients with malignant tumors. It is widely accepted and highly valued because of its brevity, reliability and clinical application, and is used to guide clinical treatment and prognosis prediction. Nevertheless, prognosis of patients in the same TNM stage is still discrepant. Apart from tumor heterogeneity and individual differences, are there any determinant clinicopathologic factors for the prognosis of gastric cancer patients beyond tumor depth, nodal status, and metastasis? Which of those factors are the key factors influencing the prognosis of gastric cancer patients? Whether those important factors could be included in the TNM staging system? Different opinions exist in this regard. Relevant prognostic factors include gender, age, tumor size, location of tumor, histological type, resection type, lymphatic/venous invasion, depth of invasion, number of metastatic lymph nodes, retrieved lymph nodes, metastatic lymph node ratio, radical …
What problem does this paper attempt to address?